Robert Shoemaker

Robert Shoemaker

Company: Erasca

Job title: Senior Vice President of Research Biology


Exploring Anti-EGFR Therapies for GBM: Case Study of a CNS-penetrant EGFR Inhibitor Developed Specifically for GBM 8:35 am

EGFR is amplified or mutated in ~60% of GBM but previous EGFR inhibitors have not shown promising activity in GBM due to a combination of poor CNS penetration and incomplete inhibition of EGFR signaling. This workshop will gather experts to discuss: Challenges which have previously held back this promising approach using examples from the recent…Read more

day: Workshop Track 2 Pre-Morning Break

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.